Carl Zeiss Meditec AG (F:AFX) — Market Cap & Net Worth
Market Cap & Net Worth: Carl Zeiss Meditec AG (AFX)
Carl Zeiss Meditec AG (F:AFX) has a market capitalization of $2.23 Billion (€1.91 Billion) as of May 2, 2026. Listed on the F stock exchange, this Germany-based company holds position #5870 globally and #894 in its home market, demonstrating a -7.21% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Carl Zeiss Meditec AG's stock price €26.26 by its total outstanding shares 87536079 (87.54 Million). Analyse AFX cash generation efficiency to see how efficiently the company converts income to cash.
Carl Zeiss Meditec AG Market Cap History: 2015 to 2026
Carl Zeiss Meditec AG's market capitalization history from 2015 to 2026. Data shows growth from $2.68 Billion to $2.69 Billion (0.63% CAGR).
Carl Zeiss Meditec AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Carl Zeiss Meditec AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.86x
Carl Zeiss Meditec AG's market cap is 1.86 times its annual revenue
Latest Price to Earnings (P/E) Ratio
29.35x
Carl Zeiss Meditec AG's market cap is 29.35 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.31 Billion | $1.09 Billion | $98.33 Million | 3.04x | 33.70x |
| 2017 | $4.99 Billion | $1.19 Billion | $134.44 Million | 4.19x | 37.12x |
| 2018 | $6.67 Billion | $1.28 Billion | $126.46 Million | 5.21x | 52.75x |
| 2019 | $11.17 Billion | $1.46 Billion | $159.76 Million | 7.65x | 69.92x |
| 2020 | $10.80 Billion | $1.34 Billion | $122.39 Million | 8.09x | 88.28x |
| 2021 | $18.44 Billion | $1.65 Billion | $236.28 Million | 11.20x | 78.06x |
| 2022 | $11.91 Billion | $1.90 Billion | $293.91 Million | 6.26x | 40.53x |
| 2023 | $9.99 Billion | $2.09 Billion | $290.40 Million | 4.78x | 34.40x |
| 2024 | $4.70 Billion | $2.07 Billion | $178.73 Million | 2.27x | 26.29x |
| 2025 | $4.14 Billion | $2.23 Billion | $141.21 Million | 1.86x | 29.35x |
Competitor Companies of AFX by Market Capitalization
Companies near Carl Zeiss Meditec AG in the global market cap rankings as of May 2, 2026.
Key companies related to Carl Zeiss Meditec AG by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #136 globally with a market cap of $162.57 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #250 globally with a market cap of $98.12 Billion USD ( €83.93 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #274 globally with a market cap of $93.24 Billion USD ( €79.76 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #523 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #136 | Intuitive Surgical Inc | NASDAQ:ISRG | $162.57 Billion | $457.78 |
| #250 | EssilorLuxottica S. A. | PA:EL | $98.12 Billion | €181.25 |
| #274 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $93.24 Billion | €88.50 |
| #523 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Carl Zeiss Meditec AG Historical Marketcap From 2015 to 2026
Between 2015 and today, Carl Zeiss Meditec AG's market cap moved from $2.68 Billion to $ 2.69 Billion, with a yearly change of 0.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €2.69 Billion | -35.16% |
| 2025 | €4.14 Billion | -11.80% |
| 2024 | €4.70 Billion | -52.96% |
| 2023 | €9.99 Billion | -16.13% |
| 2022 | €11.91 Billion | -35.42% |
| 2021 | €18.44 Billion | +70.71% |
| 2020 | €10.80 Billion | -3.27% |
| 2019 | €11.17 Billion | +67.44% |
| 2018 | €6.67 Billion | +33.67% |
| 2017 | €4.99 Billion | +50.62% |
| 2016 | €3.31 Billion | +23.59% |
| 2015 | €2.68 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Carl Zeiss Meditec AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.23 Billion USD |
| MoneyControl | $2.23 Billion USD |
| MarketWatch | $2.23 Billion USD |
| marketcap.company | $2.23 Billion USD |
| Reuters | $2.23 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Carl Zeiss Meditec AG
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for ret… Read more